Cvs Pharmacy #08262 Durable Medical Equipment & Medical Supplies Location: 39350 9 Mile Rd, Northville, Michigan 48167 Phone: (248) 735-6081 |
Cvs Pharmacy #08009 Durable Medical Equipment & Medical Supplies Location: 133 E Dunlap St, Northville, Michigan 48167 Phone: (248) 348-2010 |
Cvs Pharmacy #08163 Durable Medical Equipment & Medical Supplies Location: 16855 Haggerty Rd, Northville, Michigan 48168 Phone: (734) 420-3089 |
Meiger Pharmacy #054 Durable Medical Equipment & Medical Supplies Location: 20401 Haggerty Rd, Northville, Michigan 48167 Phone: (248) 449-5710 |
Kroger Pharmacy 18442 Community/Retail Pharmacy Location: 17447 Haggerty Rd, Northville, Michigan 48168 Phone: (248) 662-3032 |
Umhs Northville Health Center Prosthetic/Orthotic Supplier Location: 39901 Traditions Dr, Northville, Michigan 48168 Phone: (734) 973-2400 |
Northville Family Foot Specialists Medicare Supplier Location: 42925 7 Mile Rd, Northville, Michigan 48167 Phone: (248) 349-3900 |
Northville Vision Clinic Medicare Supplier Location: 42000 6 Mile Rd, Northville, Michigan 48168 Phone: (248) 348-1330 |
Northville Optical Shop Medicare Supplier Location: 39901 Traditions Dr, Northville, Michigan 48168 Phone: (248) 305-4400 |
News Archive
Medical College of Georgia researchers are seeking to refine cancer treatment with an anti-inflammatory plant derivative long used in Chinese medicine.
Through a grant awarded by the U.S. Environmental Protection Agency (EPA), the University of Maine's Center on Aging has completed the first statewide mail-back pilot program for managing pharmaceutical waste from consumers.
Welch Allyn, a leading global provider of medical diagnostic devices headquartered in Skaneateles Falls, NY, will showcase its newest generation of connected solutions designed to address the needs of busy medical practices this week at Arab Health 2012 in Dubai.
Alnylam Pharmaceuticals, Inc., a leading RNAi therapeutics company, and collaborators from the Massachusetts Institute of Technology (MIT), The University of British Columbia (UBC), AlCana Technologies, Inc., and Tekmira Pharmaceuticals Corporation, presented results from multiple ongoing research efforts regarding the discovery of novel technologies for the systemic delivery of RNAi therapeutics.
Advanced Cell Technology, Inc. announced today that the US Food and Drug Administration (FDA) has cleared the Company's Investigational New Drug (IND) application to immediately initiate a Phase I/II multicenter clinical trial using retinal cells derived from human embryonic stem cells (hESCs) to treat patients with Stargardt's Macular Dystrophy (SMD), one of the most common forms of juvenile macular degeneration in the world. The decision removes the clinical hold that the FDA had placed on the trial.
› Verified 3 days ago